BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 2000
View Archived Issues
Cerus continues phase III trial of platelet pathogen inactivation system in Europe
Read More
Two additional U.S. patents allowed for Maxamine technology
Read More
NPS Allelix drug candidate enhances bone growth in space shuttle experiments
Read More
Arena and Fujisawa establish collaboration in neurodegenerative disease area
Read More
Cambridge Drug Discovery and Parke-Davis complete screening collaboration
Read More
IND filed for nasal leuprolide as endometriosis therapy
Read More
Telik initiates clinical testing of first development candidate
Read More
Novel agent for treatment-refractory CIS now under review in Canada
Read More
Idun and Elan establish stroke therapy collaboration
Read More
Novel isatin derivatives with broad-spectrum antibacterial and antifungal activity
Read More
Alexion to commence development of 5G1.1 for treatment of dermatomyositis
Read More
Elan establishes new agreement with Wyeth-Ayerst for integrin inhibitors
Read More
Combidex contrast agent receives priority review status from FDA
Read More
Focus on carbapenem modifications continues at Merck
Read More
Emtricitabine-containing HAART regimen is highly efficacious in French study
Read More
Potent, broad-spectrum cephalosporins in development at Roche
Read More
Preliminary results in volunteers reinforce the promise of DuPont's second-generation NNRTIs
Read More
Incyte patents novel GFMOs for cancer and fibrotic disorders
Read More
Boston Life Sciences identifies target of CNS growth factor products
Read More
Novel 5-HT7 antagonists for CNS disorders under investigation at DuPont
Read More
Lilly describes 5-HT1F agonists as potential antimigraine agents
Read More
Aventis Behring launched
Read More
Lilly assesses potential utility of PLA2 inhibitors for septic shock
Read More
Roxane launches orphan drug for treatment of apnea in premature infants
Read More
BMS informs of first launch for new quinolone
Read More
Pliva presents new azithromycin derivatives at ICMASKO 5
Read More